Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | (FY)Mar 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 36.80%41.84B | 263.77%30.59B | -3.43%8.41B | -73.40%8.71B | 1,058.98%32.73B | -181.53%-3.41B | -85.29%4.19B | 117.30%28.46B | -33.38%13.1B | -33.24%19.66B |
Net profit before non-cash adjustment | 349.09%37.95B | 156.46%8.45B | 24.17%-14.97B | -117.13%-19.74B | -104.33%-9.09B | 1,737.70%209.79B | -153.52%-12.81B | 11.42%23.94B | 5.08%21.48B | -52.61%20.44B |
Total adjustment of non-cash items | -47.42%11.1B | -22.02%21.12B | 9.85%27.08B | -6.79%24.65B | 112.46%26.45B | -2,316.85%-212.2B | 293.57%9.57B | -2,195.34%-4.95B | -87.26%236M | 139.79%1.85B |
-Depreciation and amortization | -7.92%17.25B | 1.42%18.74B | 1.81%18.48B | 1.54%18.15B | 36.78%17.87B | 100.81%13.07B | 64.07%6.51B | 22.26%3.97B | 58.71%3.24B | -5.46%2.04B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | --7.48B | ---- | 163.95%227M | --86M | ---- |
-Share of associates | 156.83%6.75B | 269.70%2.63B | -6.10%-1.55B | 11.58%-1.46B | 40.97%-1.65B | -336.72%-2.8B | 72.96%-640M | ---2.37B | ---- | ---- |
-Disposal profit | -95.61%134M | -26.00%3.05B | 245.06%4.12B | 6.42%1.19B | 27,950.00%1.12B | 120.00%4M | 98.90%-20M | -451.84%-1.81B | 572.48%515M | 58.56%-109M |
-Net exchange gains and losses | 21.92%-6.58B | -75.72%-8.43B | -23.44%-4.8B | -555.48%-3.89B | 91.79%-593M | -349.57%-7.22B | 155.61%2.89B | -29.08%-5.2B | -702.79%-4.03B | 84.00%-502M |
-Other non-cash items | -225.71%-6.45B | -52.61%5.13B | 1.61%10.83B | 9.89%10.66B | 104.35%9.7B | -26,871.03%-222.74B | 242.39%832M | -42.28%243M | 0.48%421M | -16.20%419M |
Changes in working capital | -807.76%-7.21B | 127.46%1.02B | -197.86%-3.71B | -75.35%3.79B | 1,626.12%15.37B | -113.57%-1.01B | -21.60%7.42B | 209.76%9.47B | -226.83%-8.63B | 70.79%-2.64B |
-Change in receivables | -602.43%-6.21B | 134.29%1.24B | -182.10%-3.61B | 77.85%4.39B | 150.65%2.47B | -250.42%-4.88B | -74.47%3.24B | 293.11%12.7B | 25.55%-6.58B | -11.26%-8.83B |
-Change in inventory | 81.83%-461M | -137.10%-2.54B | -170.67%-1.07B | 169.77%1.51B | -148.86%-2.17B | -40.83%4.44B | 152.16%7.51B | -294.03%-14.39B | -160.67%-3.65B | 67.43%-1.4B |
-Change in payables | -86.58%350M | 76.76%2.61B | 7,480.00%1.48B | -101.10%-20M | 201.84%1.82B | 77.07%-1.79B | -159.83%-7.81B | 2,155.91%13.06B | -116.06%-635M | -45.72%3.96B |
-Provision for loans, leases and other losses | 104.24%59M | -310.93%-1.39B | -61.73%659M | 382.35%1.72B | --357M | ---- | ---- | 66.22%625M | 504.30%376M | -109.24%-93M |
-Changes in other current assets | 247.70%353M | 61.26%-239M | 73.96%-617M | -1,816.67%-2.37B | 104.37%138M | -703.05%-3.16B | 68.10%-393M | -493.61%-1.23B | -52.43%313M | 111.83%658M |
-Changes in other current liabilities | -196.79%-1.3B | 343.45%1.34B | 62.07%-550M | -111.37%-1.45B | 191.50%12.75B | -10.35%4.37B | 478.80%4.88B | -183.20%-1.29B | -49.63%1.55B | 551.06%3.07B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -53.86%-13.82B | -42.10%-8.98B | -19.76%-6.32B | 1.60%-5.28B | -202.88%-5.36B | -236.69%-1.77B | -24.94%-526M | -10.21%-421M | 18.90%-382M | -214.00%-471M |
Interest received (cash flow from operating activities) | 137.01%365M | 35.09%154M | -17.99%114M | -35.35%139M | -99.71%215M | 22,090.50%74.78B | -21.08%337M | 344.79%427M | -75.38%96M | 257.80%390M |
Tax refund paid | 9.07%-371M | 10.53%-408M | 0.00%-456M | -124.18%-456M | 103.66%1.89B | -734.64%-51.54B | 33.90%-6.18B | 17.33%-9.34B | 31.87%-11.3B | -1,163.21%-16.59B |
Other operating cash inflow (outflow) | 0 | 3.11B | 0 | 0 | 100.04%1M | -278,000.00%-2.78B | 200.00%1M | 0.00%-1M | -1M | 0 |
Operating cash flow | 14.54%28.02B | 1,301.78%24.46B | -43.93%1.75B | -89.44%3.11B | 92.85%29.47B | 801.88%15.28B | -111.39%-2.18B | 1,167.77%19.12B | -49.57%1.51B | -89.35%2.99B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -45.28%-10.9B | 10.99%-7.5B | 26.72%-8.43B | 58.16%-11.5B | 44.94%-27.49B | 12.71%-49.92B | 18.07%-57.19B | -290.48%-69.8B | 31.20%-17.87B | -127.40%-25.98B |
Net intangibles purchase and sale | -54.97%-764M | -103.72%-493M | 37.63%-242M | 48.27%-388M | 7.98%-750M | 34.06%-815M | -85.86%-1.24B | 13.64%-665M | -48.08%-770M | 16.26%-520M |
Net business purchase and sale | ---- | ---- | ---- | ---- | -27,020.00%-1.36B | 99.17%-5M | ---606M | ---- | ---- | 71.56%-223M |
Net investment product transactions | -11.11%-10M | -101.94%-9M | 4,750.00%465M | 9.09%-10M | -100.01%-11M | 3,446,900.00%206.81B | 99.59%-6M | -16,222.22%-1.47B | 99.82%-9M | -230.50%-4.97B |
Advance cash and loans provided to other parties | 60.06%-800M | -1,688.39%-2B | 98.27%-112M | -167.88%-6.48B | -55.06%-2.42B | 0.38%-1.56B | -1,720.93%-1.57B | ---86M | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | 25.50%1.71B | -36.90%1.36B | 2,701.30%2.16B | -97.27%77M | 2,306.84%2.82B | --117M | ---- | ---- | ---- | ---- |
Net changes in other investments | 281.25%638M | 59.95%-352M | -348.47%-879M | -163.43%-196M | 40.45%309M | -68.44%220M | -86.37%697M | -25.32%5.12B | 45.32%6.85B | 161.01%4.71B |
Investing cash flow | -12.54%-10.12B | -27.84%-9B | 61.95%-7.04B | 35.99%-18.5B | -118.66%-28.9B | 358.50%154.85B | 10.46%-59.9B | -466.76%-66.9B | 56.26%-11.8B | -22.32%-26.98B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 27.59%-7.7B | -1,013.19%-10.63B | -105.63%-955M | 2,897.88%16.97B | 100.35%566M | -2,275.75%-160.72B | -86.77%7.39B | 487.50%55.85B | 586.04%9.51B | -120.12%-1.96B |
Net common stock issuance | ---- | ---- | ---- | 38.21%-1.74B | -6,511.36%-2.82B | -38.03%44M | --71M | ---- | ---- | ---- |
Increase or decrease of lease financing | 47.14%-434M | -18.64%-821M | -3.13%-692M | 9.45%-671M | 7.84%-741M | -4,629.41%-804M | -100.30%-17M | --5.69B | ---- | ---- |
Cash dividends paid | ---3.1B | ---- | ---- | ---- | ---5.87B | ---- | 4.45%-3.16B | -80.04%-3.3B | -25.02%-1.83B | 66.88%-1.47B |
Net other fund-raising expenses | -146.12%-95M | 219.77%206M | -45.76%-172M | ---118M | ---- | -2,660.61%-1.69B | 104.19%66M | -116.02%-1.58B | 2,352.17%9.84B | 93.73%-437M |
Financing cash flow | -0.71%-11.33B | -518.25%-11.25B | -112.60%-1.82B | 262.88%14.44B | 94.57%-8.86B | -3,849.38%-163.17B | -92.32%4.35B | 223.51%56.66B | 553.76%17.52B | -20.14%-3.86B |
Net cash flow | ||||||||||
Beginning cash position | 17.18%35.79B | -17.74%30.55B | -2.86%37.13B | -16.66%38.23B | 28.87%45.87B | -70.10%35.59B | 202.46%119.04B | 36.92%39.36B | -45.54%28.74B | 13.73%52.78B |
Current changes in cash | 55.65%6.57B | 159.33%4.22B | -650.11%-7.11B | 88.57%-948M | -219.21%-8.29B | 112.05%6.96B | -750.09%-57.73B | 23.01%8.88B | 125.92%7.22B | -1,089.48%-27.85B |
Effect of exchange rate changes | 62.04%1.83B | 115.65%1.13B | 493.98%524M | -120.56%-133M | -80.51%647M | 723.82%3.32B | -88.87%403M | 6.72%3.62B | -11.23%3.39B | 12.95%3.82B |
Cash adjustments other than cash changes | 99.02%-1M | ---102M | ---- | -1,300.00%-12M | --1M | ---- | -7,627.51%-26.12B | -17,000.00%-338M | 200.00%2M | -101.16%-2M |
End cash Position | 23.46%44.19B | 17.18%35.79B | -17.74%30.55B | -2.86%37.13B | -16.66%38.23B | 28.87%45.87B | -30.91%35.59B | 30.90%51.52B | 36.92%39.36B | -45.54%28.74B |
Free cash flow | -0.91%16.28B | 337.38%16.43B | 21.11%-6.92B | -812.26%-8.78B | 103.48%1.23B | 41.50%-35.45B | -17.25%-60.6B | -201.34%-51.68B | 27.26%-17.15B | -247.05%-23.58B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |